Citation Impact
Citing Papers
Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder Cancer
2006
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
An Investigation Into the Prognostic Significance of Necrosis and Hypoxia in High Grade and Invasive Bladder Cancer
2007
Lymph Node Dissection Technique Is More Important Than Lymph Node Count in Identifying Nodal Metastases in Radical Cystectomy Patients: A Comparative Mapping Study
2011
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription
2003
After Cystectomy, Is It Justified to Perform a Bladder Replacement for Patients with Lymph Node Positive Bladder Cancer?
2002
Template‐based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival
2010
Optimal Management of the T1G3 Bladder Cancer
2005
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Applications of novel drug delivery system for herbal formulations
2010 Standout
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
2013
Cancer‐specific survival after radical cystectomy and standardized extended lymphadenectomy for node‐positive bladder cancer: prediction by lymph node positivity and density
2009
Strategies to improve drug delivery in bladder cancer therapy
2009
Contribution of platelets to tumour metastasis
2011 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
Guidelines on Bladder Cancer
2002
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
2008 Standout
Design and development of polymers for gene delivery
2005 Standout
Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical Prostatectomy
2007
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure
2006
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
2012
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
A New Multimodality Technique Accurately Maps the Primary Lymphatic Landing Sites of the Bladder
2009
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Urothelial Carcinoma of the Prostate
2007
Future strategies in the diagnosis, staging and treatment of bladder cancer
2003
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer
2004 Standout
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Collagen I:III ratio in canine heterologous bladder acellular matrix grafts
2006
The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review
2014
EAU Guidelines on Prostate Cancer
2007 Standout
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs
2006
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Extent of lymph node dissection and recurrence-free survival after radical cystectomy: A meta-analysis
2014
Anatomic Basis for Lymph Node Counts as Measure of Lymph Node Dissection Extent: A Cadaveric Study
2013
Cellular and molecular actions of Methylene Blue in the nervous system
2009
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience
2010
Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
2011
Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer
2011
Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genes
2004
Interleukin‐6 and its receptor in cancer
2007
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens
2012
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
2012
Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer
2008
Decolorization of Methylene Blue and Malachite Green by Immobilized Desmodesmus sp. Isolated from North Jordan
2015
The first 30 years of p53: growing ever more complex
2009 Standout
Systematic Review and Cumulative Analysis of Oncologic and Functional Outcomes After Robot-assisted Radical Cystectomy
2015
Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers
2005
Neuroinflammation: the devil is in the details
2016 Standout
THE PREDICTIVE VALUE OF MUSCULARIS MUCOSAE INVASION AND p53 OVER EXPRESSION ON PROGRESSION OF STAGE T1 BLADDER CARCINOMA
2001
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Results with radical cystectomy for treating bladder cancer: a ‘reference standard’ for high‐grade, invasive bladder cancer
2003
Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results
2010
Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy
2005
The Role of Perioperative Chemotherapy in the Treatment of Urothelial Cancer
2006
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
2000
Extended vs non‐extended pelvic lymph node dissection and their influence on recurrence‐free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta‐analysis of comparative studies
2013
Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer
2006
BILATERAL EXTRAVESICAL URETERAL REIMPLANTATION IN TOILET TRAINED CHILDREN: IS 1-DAY HOSPITALIZATION WITHOUT URINARY RETENTION POSSIBLE?
2005
Bladder Cancer
2020 Standout
Impact of the Extent of Regional Lymphadenectomy on the Survival of Patients With Urothelial Carcinoma of the Upper Urinary Tract
2007
Lymphovascular Invasion of Urothelial Cancer in Matched Transurethral Bladder Tumor Resection and Radical Cystectomy Specimens
2008
Impact of pretreatment thrombocytosis on survival in primary breast cancer
2003
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
Lymphovascular Invasion in Transurethral Resection Specimens as Predictor of Progression and Metastasis in Patients With Newly Diagnosed T1 Bladder Urothelial Cancer
2009
Efficiency of various recent wastewater dye removal methods: A review
2018 Standout
Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium
2006
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
2017
Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
2011
Cytokine therapy in renal cell cancer
2000
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
PROGNOSTIC SIGNIFICANCE OF LYMPHOVASCULAR INVASION OF BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY
2005
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
2004 StandoutScience
Works of J. Leißner being referenced
Methylene blue staining for nerve-sparing operative procedures: an animal model
2004
Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study
1998
Prognostic Value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 Immunoreactivity in pT1 G3 Urothelial Bladder Carcinomas
2001
Prognostic Significance of Histopathological Grading and Immunoreactivity for p53 and p21/WAF1 in Grade 2 pTa Transitional Cell Carcinoma of the Urinary Bladder
2001
Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis
2000
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
2018
p53 Immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder — a helpful parameter in guiding the decision for or against cystectomy?
2000
Colon pouch (Mainz pouch III) for continent urinary diversion after pelvic irradiation
2000
THE PELVIC PLEXUS AND ANTIREFLUX SURGERY: TOPOGRAPHICAL FINDINGS AND CLINICAL CONSEQUENCES
2001
Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation
2002
Refluxing Ureterointestinal Anastomosis for Continent Cutaneous Urinary Diversion
2002
Prognostic Significance of Vascular and Perineural Invasion in Urothelial Bladder Cancer Treated With Radical Cystectomy
2003
Die Bedeutung der pelvinen Lymphadenektomie für die Prognose nach radikaler Zystektomie
2002
Risk of Detrusor Denervation in Antireflux Surgery Demonstrated in a Neurophysiological Animal Model
2003
Extended Radical Lymphadenectomy in Patients With Urothelial Bladder Cancer:: Results of a Prospective Multicenter Study
2004